dc.contributor.author | POPA, Cristina | |
dc.contributor.author | STRATAN, Valentina | |
dc.contributor.author | TUTUIANU, Valeri | |
dc.contributor.author | SITNIC, Victor | |
dc.contributor.author | BALAN, Veronica | |
dc.contributor.author | NOVAC, Mihail | |
dc.contributor.author | SPRINCEAN, Mariana | |
dc.contributor.author | CASIAN, Neonila | |
dc.date.accessioned | 2024-04-25T07:39:44Z | |
dc.date.available | 2024-04-25T07:39:44Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | POPA, Cristina et al. Prevalence of some PIK3CA mutations in patients with cervical Squamous Carcinoma from the Republic of Moldova. In: Quo Vadis – Ethics of the Scientific Research: conf. NANO-2024, event devoted to the 60th anniversary of the Technical University of Moldova, 15-18 April 2024, Chişinău, Republica Moldova: Program and proceedings of the conference, Chişinău 2024, pp. 59-60. ISBN 978-9975-64-422-8. | en_US |
dc.identifier.isbn | 978-9975-64-422-8 | |
dc.identifier.uri | http://repository.utm.md/handle/5014/26905 | |
dc.description.abstract | The study aimed to determine the prevalence of mutations in the PIK3CA gene in a cohort of CSCC patients from the Republic of Moldova. The tested prevalence of the PIK3CA mutations was 29.35%. Testing revealed that 25 patients were positive for a single mutation, and two tested positive for a double mutation. Since many patients have these mutations, there is a chance that CSCC patients from the Republic of Moldova will benefit from the development of anti-PI3K targeted therapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Technical University of Moldova | en_US |
dc.relation.ispartofseries | NANO-2024 "Quo Vadis – Ethics of the Scientific Research", event devoted to the 60th anniversary of the Technical University of Moldova;15-18 April 2024, Chişinău, Republica Moldova | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | * |
dc.subject | cervical squamous cell carcinoma | en_US |
dc.subject | targeted therapy | en_US |
dc.title | Prevalence of some PIK3CA mutations in patients with cervical Squamous Carcinoma from the Republic of Moldova | en_US |
dc.type | Article | en_US |
The following license files are associated with this item: